Factors affecting the use of salbutamol before hospital admission in children with asthma exacerbation
Main Article Content
Keywords
asthma attack, beta-agonist, children, exacerbation, modified pulmonary index score, parents’ knowledge, salbutamol, severity
Abstract
Background: Early home intervention for asthma exacerbation (AE) in children is associated with more favorable outcomes. Inhaled short-acting beta2 agonists (SABA) are the cornerstones of AE treatment.
Objectives: We aimed to determine what proportion of parents administered salbutamol to their children to treat asthma exacerbation at home, and the factors affecting the decision to administer the medication. Additionally, we also aimed to examine the parents’ level of knowledge regarding salbutamol use.
Methods: Asthma patients who were admitted to pediatric allergy outpatient clinics due to AE were included in the study. Parents’ knowledge related to home salbutamol use was evaluated using a questionnaire. Modified Pulmonary Index Score was used to evaluate AE severity.
Results: The study included 177 children (64.4% males) with a median age of 6.16 years. Of these, 86 patients (48.6%) had not administered salbutamol before hospital admission, and parents of 69 (80%) patients stated that they knew salbutamol should be administered but they did not want to administer it without consulting a doctor. Of the 91 patients who had used salbutamol before hospital admission, 28 (30.7%) had administered the incorrect dose, 2 (2.2%) used the incorrect technique, and 9 (9.9%) had the incorrect dose and incorrect technique. In multivariate logistic regression analysis, history of hospitalizations (odds ratio [OR]: 6.35; 95% confidence interval [CI]: 3.07–13.9; P < 0.001), history of more than five exacerbations (OR: 4.51, 95%CI: 1.94–10.48; P < 0.001 ), and presence of sputum (OR: 2.54; 95%CI: 1.10–5.87; P = 0.028) were the main predictors of salbutamol use.
Conclusion: Asthma patients and their parents should be better educated and actively encouraged on the use of SABA at home during an AE.
References
2 Moorman JE, Akinbami LJ, Bailey CM, Zahran HS, King ME, Johnson CA, et al. National surveillance of asthma: United States, 2001–2010. Vital Health Stat 2012;35:1–67.
3 Toyran M, Yagmur IT, Guvenir H, Haci IA, Bahceci S, Batmaz SB, et al. Asthma control affects school absence, achievement and quality of school life: A multicenter study. Allergol Immunopathol (Madr). 2020;48(6):545–52. 10.1016/j.aller.2020.05.005
4 Bellin MH, Land C, Newsome A, Kub J, Mudd SS, Bollinger ME, et al. Caregiver perception of asthma management of children in the context of poverty. J Asthma. 2017;54:162–72. 10.1080/02770903.2016.1198375
5 Gibson-Young L, Turner-Henson A, Gerald LB, Vance DE, Lozano D. The relationships among family management behaviors and asthma morbidity in maternal caregivers of children with asthma. J Fam Nurs. 2014;20:442–61. 10.1177/1074840714552845
6 Global Initiative for Asthma (GINA). Global Strategy for Asthma Management and Prevention, 2019. [cited 2020 October 10]. Available from: https://ginasthma.org/wp-content/uploads/2019/06/GINA-2019-main-report-June-2019-wms.pdf
7 Pollart SM, Compton RM, Elward KS. Management of acute asthma exacerbations. Am Fam Physician. 2011;84:40–7.
8 Emeryk A, Emeryk Maksymiuk J. Short-acting inhaled beta2-agonists: Why, whom, what, how? Adv Respir Med. 2020;88:443–9. 10.5603/ARM.a2020.0132
9 Lieu TA, Quesenberry CP, Capra AM, Sorel ME, Martin KE, Mendoza GR. Outpatient management practices associated with reduced risk of pediatric asthma Hospitalization and Emergency Visits. Pediatrics. 1997;100:334–41. 10.1542/peds.100.3.334
10 Carroll CL, Sekaran AK, Lerer TJ, Schramm CM. A modified pulmonary index score with predictive value for pediatric asthma exacerbations. Ann Allergy Asthma Immunol. 2005;94:355–9. 10.1016/S1081-1206(10)60987-8
11 American Thoracic Society. Standardization of Spirometry, 1994 Update. Am J Respir Crit Care Med. 1995;152:1107–36. 10.1164/ajrccm.152.3.7663792
12 Pardue Jones B, Fleming GM, Otillio JK, Asokan I, Arnold DH. Pediatric acute asthma exacerbations: Evaluation and management from emergency department to intensive care unit. J Asthma. 2016;53:607–17. 10.3109/02770903.2015.1067323
13 Ungar WJ, Paterson JM, Gomes T, Bikangaga P, Gold M, To T, et al. Relationship of asthma management, socioeconomic status, and medication insurance characteristics to exacerbation frequency in children with asthma. Ann Allergy Asthma Immunol. 2011;106:17–23. 10.1016/j.anai.2010.10.006
14 McQuaid EL, Koinis Mitchell D, Walders N, Nassau JH, Kopel SJ, Klein RB, et al. Pediatric asthma morbidity: The importance of symptom perception and family response to symptoms. J Pediatr Psychol. 2007;32:167–77. 10.1093/jpepsy/jsj112
15 Garbutt JM, Freiner D, Highstein GR, Nelson KA, Smith SR, Strunk RC. Home use of albuterol for asthma exacerbations. Ann Allergy Asthma Immunol. 2009;102:504–9. 10.1016/S1081-1206(10)60125-1
16 Gibson-Young LM, Aroian KJ, Weglicki LS, Lang JE, Norris CL Interviews with caregivers during acute asthma hospitalisations. J Asthma. 2020;57:778–86. 10.1080/02770903.2019.1602875
17 Cabana MD, Le TT. Challenges in asthma patient education. J Allergy Clin Immunol. 2005;115:1225–7. 10.1016/j.jaci.2005.03.004
18 Borgemeyer A, Gyr PM, Jamerson PA, Henry LD. Evaluation of the role of pediatric nurse practitioner in an inpatient asthma program. J Pediatr Health Care. 2008;22:273–81. 10.1016/j.pedhc.2007.07.004
19 Warman KL, Silver EJ, McCourt MP, Stein RE. How does home management of asthma exacerbations by parents of inner-city children differ from NHLBI guideline recommendations? Pediatrics. 1999;103:422–7. 10.1542/peds.103.2.422
20 Lefevre F, Piper M, Weiss K, Mark D, Clark N, Aronson N. Do written action plans improve patient outcomes in asthma? An evidence-based analysis. J Fam Pract. 2002;51:842–8.
21 Pollock M, Sinha IP, Hartling L, Rowe BH, Schreiber S, Fernandes RM. Inhaled short-acting bronchodilators for managing emergency childhood asthma: An overview of reviews. Allergy. 2017;72:183–200. 10.1111/all.13039